Parabacteroides distasonis
(
Pdis
) is the type species for the new
Parabacteroides
genus, and a gut commensal of the
Bacteroidetes
phylum. Emerging reports (primarily based on reference strain/ATCC-8503) concerningly propose that long-known opportunistic pathogen
Pdis
is a probiotic. We posit there is an urgent need to characterize the pathogenicity of
Pdis
strain-strain variability. Unfortunately, no methods/insights exist to classify
Bacteroidetes
for this purpose. Herein, we developed a virulence gene-based classification system for
Pdis
and
Bacteroidetes
to facilitate pathogenic-vs-probiotic characterization. We used DNA
in silico
methods to develop a system based on the virulence (lipopolysaccharide/bacterial wall) ‘
rfbA
O-antigen-synthesis gene’. We then performed phylogenetic analysis of
rfbA
from fourteen
Pdis
complete genomes (21 genes), other
Parabacteroides, Bacteroidetes
, and
Enterobacteriaceae
; and proposed a PCR-based Restriction-Fragment Length Polymorphism method. Cluster analysis revealed that
Pdis
can be classified into four lineages (based on gene gaps/insertions) which we designated
rfbA
-Types I, II, III, and IV. In context, we found 14 additional
rfbA
-types (I–XVIII) interspersed with numerous
Bacteroidetes
and pathogenic
Enterobacteriaceae
forming three major “
rfbA
-superclusters.” For laboratory
rfbA
-Typing implementation, we developed a PCR-primer strategy to amplify
Pdis rfbA
genes (100%-specificity) to conduct MboII-RFLP and sub-classify
Pdis. In-silico
primers for other
Bacteroidetes
are proposed/discussed. Comparative analysis of lipopolysaccharide/lipid-A gene
lpxK
confirmed
rfbA
as highly discriminant. In conclusion,
rfbA
-Typing classifies
Bacteroidetes/Pdis
into unique clusters/superclusters given
rfbA
copy/sequence variability. Analysis revealed that most pathogenic
Pdis
strains are single-copy
rfbA
-Type I . The relevance of the
rfbA
strain variability in disease might depend on their hypothetical modulatory interactions with other O-antigens/lipopolysaccharides and TLR4 lipopolysaccharide-receptors in human/animal cells.